Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a frailty score predict which older cancer patients survive intensive care?

NCT ID NCT07825090

Knowledge-focused Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Older adults with cancer who need intensive care often face a higher risk of dying, and delays in moving them from the emergency department to the ICU may add to that risk. This study reviews the medical records of 150 patients aged 65 and older with solid or blood cancers who were admitted from the emergency department to an anesthesiology and reanimation intensive care unit. Researchers examine whether the time spent waiting for an ICU bed, the patient's age group, and a frailty score are linked to death within 30 days. They also look at how these factors relate to how long patients stay in the ICU and hospital, and whether they die during the hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study finds a link, hospitals could use frailty scores and wait times to flag older cancer patients at higher risk and prioritize their intensive care.
What could go wrong
This is a small, single-center review of past records, so it can show patterns but not prove cause and effect. Its findings may not apply to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Geriatric oncology patients aged 65 years and older who were admitted from the Emergency Department to the Anesthesiology and Reanimation Intensive Care Unit between January 1, 2026 and July 1, 2026.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 65 years * Diagnosis of solid or hematologic malignancy * Admission from the Emergency Department to the Anesthesiology and Reanimation Intensive Care Unit * ICU admission between January 1, 2026 and July 1, 2026 Exclusion Criteria: * Age \< 65 years * Missing data regarding boarding time, Clinical Frailty Scale score, or 30-day mortality * Readmission to the ICU during the same hospitalization * Patients transferred from hospital wards or other ICUs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Frailty hematopoietic and lymphoid cell neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Frailty Mortality

Contacts and locations

Locations

  • Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital

    Yenimahalle, Ankara, 0620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.